Dendritic Cell Subset for Enhanced Cancer Vaccine

Award Information
Agency:
Department of Health and Human Services
Branch:
N/A
Amount:
$109,586.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43CA105686-01A1
Agency Tracking Number:
CA105686
Solicitation Year:
2004
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Small Business Information
AASTROM BIOSCIENCES, INC.
AASTROM BIOSCIENCES, INC., BOX 376, ANN ARBOR, MI, 48105
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
N/A
Principal Investigator
 DOUGLAS Smith
 (734) 930-5789
 DSMITH@AASTROM.COM
Business Contact
 ALAN WRIGHT
Phone: (734) 930-5555
Email: AWRIGHT@AASTROM.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Tumor antigen primed dendritic cells (DCs) are under widespread clinical evaluation for immunotherapy of multiple forms of cancer. Emerging evidence suggests that DCs are fundamental regulators of the immune response

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government